Prehospital paediatric emergencies in Belgium: an epidemiologic study

Laurent Houtekie1, Philippe Meert, Frédéric Thys

  • 1Departments of aAcute Medicine bPediatrics, St-Luc University Hospital, Brussels, Belgium.

Insights

Belgian emergency medical services (EMS) rarely encounter life-threatening pediatric emergencies. While most children treated by EMS have medical conditions, advanced interventions are uncommon, and outcomes for critical cases remain poor.

Area of Science:

  • Pediatric Emergency Medicine
  • Emergency Medical Services (EMS)
  • Public Health

Background:

  • Emergency medical services in Belgium are regulated, with medical teams mandated in specific procedures.
  • Data on pediatric involvement in emergency medical services within Belgium is limited.
  • Understanding pediatric emergency cases is crucial for improving prehospital care.

Purpose of the Study:

  • To analyze the characteristics of children treated by emergency medical services in Belgium.
  • To identify common pathologies and specific needs of pediatric patients in prehospital settings.
  • To inform the development of targeted emergency medical interventions for children.

Main Methods:

  • Retrospective review of pediatric patients (<16 years) managed by an EMS team.
  • Data collected over a two-year period (2010-2011).
  • Analysis of patient demographics, medical conditions, diagnoses, and outcomes.

Main Results:

  • 229 pediatric missions were conducted between 2010-2011.
  • 76% of pediatric cases presented with medical conditions, with seizures (34.1%) being the most frequent diagnosis.
  • Cardiac arrest occurred in 2.2% of cases, all resulting in fatalities; 26.6% required medication, and 43.2% were discharged from the emergency room.

Conclusions:

  • Prehospital pediatric emergencies are infrequently life-threatening and rarely require advanced medical interventions.
  • The outcomes for pediatric patients experiencing severe, life-threatening emergencies remain poor.
  • There is a clear need for enhanced training for EMS teams to manage critical pediatric cases effectively.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
554
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
749
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
116